论文部分内容阅读
2015年12月13日,生物类似药研发与评价技术指导原则实施和科学问题研讨会在北京召开。本次会议由中国药学会主办,中国药学会生物药品与质量研究专业委员承办,安进公司、安捷伦科技(中国)有限公司协办。会议旨在深入探讨我国生物类似药技术指导原则颁布之后顺利实施相关法规和评价标准,来自国内外研发机构、生产企业、监管领域等领导和专家、科技人员240人参加了会议。
On December 13, 2015, a Symposium on Implementation of Guiding Principles for Biosimilars R & D and Evaluation and Scientific Issues was held in Beijing. This meeting is sponsored by the Chinese Pharmaceutical Association, the Chinese Pharmaceutical Association biological medicine and quality research professional contractors, Amgen, Agilent Technologies (China) Co., Ltd. in co-operation. The conference aimed to probe into the smooth implementation of the relevant laws and regulations and evaluation standards after the promulgation of the guiding principles for bio-similar drug technology in China. 240 experts, scientific and technical personnel from domestic and foreign R & D institutions, manufacturing enterprises and regulatory authorities attended the conference.